Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 10 of 10 entries
View as:

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Phase: N/A Priority: Normal
NCT ID: NCT05662202 Org: User:
Start: 12/12/22 End: 05/31/26 Due: 05/31/27

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

Phase: N/A Priority: Normal
NCT ID: NCT05060237 Org: User:
Start: 12/01/21 End: 04/20/23 Due: 04/20/24

Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).

Phase: N/A Priority: Normal
NCT ID: NCT03573401 Org: User:
Start: 09/25/18 End: 02/28/29 Due: 02/28/30

Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.

Phase: N/A Priority: Normal
NCT ID: NCT02799082 Org: User:
Start: 12/31/07 End: 10/31/08 Due: 10/31/09

Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02799069 Org: User:
Start: 04/30/08 End: 08/31/09 Due: 08/31/10

Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02144077 Org: User:
Start: 01/28/14 End: 09/09/20 Due: 09/09/21

Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults

Phase: N/A Priority: Normal
NCT ID: NCT05080764 Org: User:
Start: 12/10/21 End: 11/30/25 Due: 11/30/26

Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)

Phase: N/A Priority: Normal
NCT ID: NCT04319159 Org: User:
Start: 03/05/20 End: 10/07/20 Due: 10/07/21

A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT02799030 Org: User:
Start: 10/31/06 End: 03/31/07 Due: 03/31/08

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

Phase: N/A Priority: Normal
NCT ID: NCT01966120 Org: User:
Start: 10/31/13 End: 04/30/15 Due: 04/30/16